FHI vs MORN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

FHI

61.6
AI Score
VS
FHI Wins

MORN

58.8
AI Score

Investment Advisor Scores

FHI

Sep 28, 2026
62score
Recommendation
HOLD

MORN

Sep 28, 2026
59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI MORN Winner
Forward P/E 9.9206 19.802 FHI
PEG Ratio 1.3978 2.31 FHI
Revenue Growth 18.3% 9.6% FHI
Earnings Growth 19.3% 35.4% MORN
Tradestie Score 61.6/100 58.8/100 FHI
Profit Margin 21.3% 16.4% FHI
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

FHI 1M: -11.2% · 3M: +0.5% MORN 1M: -7.7% · 3M: +26.7%

Current Technical Phase

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.8 · Price: $57.82

MORN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.3 · Price: $195.98

Fundamentals Snapshot

Metric FHI MORN
Market Cap — —
Forward P/E 9.8 14.1
Trailing P/E 10.7 19.1
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.7% 0.6%
Operating Margin 0.3% 0.2%
EPS 5.37 10.31
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.